Norwegian suitors show interest in a failed “gigafactory” company that is being sold.
Breaking: Australian battery maker makes a bid for Britishvolt
A start-up based in Australia has offered to rescue Britishvolt, the failing electric battery manufacturer. Britishvolt went bankrupt this month.
Omega Diagnostics Gp (AIM:ODX) Trading update
Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, provides a trading update which reflects lower than expected revenue,
Electric car battery maker Britishvolt enters administration
Britishvolt was the maker of electric vehicle batteries. They have appointed administrators and made around 300 employees redundant.
Omega Diagnostics Gp (AIM:ODX) US expansion update
Maiden US Laboratory FoodPrint® installation,
EQTEC PLC (AIM:EQT) Deeside Project SPV Sale and Trading Updates
EQTEC plc (AIM: EQT), a global technology innovator powering distributed, decarbonised, new energy infrastructure through its waste-to-value solutions for hydrogen, biofuels, and energy generation, provides the following update regarding the
BMW is set to move production of its electric minis from the United Kingdom to China
BMW plans to end all UK production of its award-winning electric Mini and move it to China. This will severely undermine any hopes that Britain can be a global center
Omega Diagnostics Gp (AIM:ODX) Positive WHO data received for VISITECT® CD4 test
Test shows high diagnostic accuracy (specificity and sensitivity)
EQTEC PLC (AIM:EQT) Heads of Terms toward Sale of Deeside Project
EQTEC plc (AIM: EQT), a world-leading technology innovation company enabling the Net Zero Future through advanced solutions for hydrogen, biofuels, SNG and other energy production is pleased to announce that,
Omega Diagnostics Gp (AIM:ODX) Change of preliminary results date
Change of preliminary results date and investor presentation and update to CD4 sale
Omega Diagnostics Gp (AIM:ODX) Completion of Sale of the CD4 Business
Completion of Sale of the CD4 Business